9 Meters Biopharma (NMTR) –
-
Form 25-NSE 9 METERS BIOPHARMA, INC. Filed by: Nasdaq Stock Market LLC
-
Form 144 9 METERS BIOPHARMA, INC. Filed by: Sensenig Bethany
-
Form 144 9 METERS BIOPHARMA, INC. Filed by: Sirgo Mark A
-
9 Meters Biopharma (NMTR) Files for Bankruptcy, Ceases Operations
-
Form 8-K 9 METERS BIOPHARMA, INC. For: Jul 17
-
Form 8-K 9 METERS BIOPHARMA, INC. For: Jun 12
-
Form 8-K 9 METERS BIOPHARMA, INC. For: May 26
-
9 Meters Biopharma (NMTR) Announces Management Change and Provides Clinical Update on Vurolenatide in Patients with Short Bowel Syndrome
-
9 Meters Biopharma Announces Management Change and Provides Clinical Update on Vurolenatide in Patients with Short Bowel Syndrome
-
Brookline Capital Markets Downgrades 9 Meter Biopharma (NMTR) to Hold
-
Form 8-K 9 METERS BIOPHARMA, INC. For: May 19
-
Form PRE 14A 9 METERS BIOPHARMA, INC. For: May 19
-
Form 8-K 9 METERS BIOPHARMA, INC. For: May 18
-
9 Meter Biopharma (NMTR) PT Lowered to $0.75 at Citi
-
9 Meters Biopharma, Inc. (NMTR) Misses Q1 EPS by 98c
-
Form 10-Q 9 METERS BIOPHARMA, INC. For: Mar 31
-
9 Meters Biopharma (NMTR) Reports Q1, Provides Business Update
-
Form 8-K 9 METERS BIOPHARMA, INC. For: May 15
-
9 Meters Biopharma Provides Business Update and Reports Financial Results for First Quarter 2023
-
Form 10-K/A 9 METERS BIOPHARMA, INC. For: Dec 31
-
Form 8-K 9 METERS BIOPHARMA, INC. For: Apr 26
-
Form 144 9 METERS BIOPHARMA, INC. Filed by: Sensenig Bethany
-
Form 4 9 METERS BIOPHARMA, INC. For: Apr 21 Filed by: Sensenig Bethany
-
Form 8-K 9 METERS BIOPHARMA, INC. For: Mar 31
-
Form 8-K 9 METERS BIOPHARMA, INC. For: Apr 05
-
9 Meters Biopharma (NMTR) Announces Successful Pre-IND Meeting with FDA Regarding Its GIP Antagonist NM-136 for Obesity
-
9 Meters Biopharma Announces Successful Pre-IND Meeting with FDA Regarding Its GIP Antagonist NM-136 for Obesity
-
Form 4 9 METERS BIOPHARMA, INC. For: Mar 29 Filed by: Sirgo Mark A
-
Form 4 9 METERS BIOPHARMA, INC. For: Mar 29 Filed by: RICE YEHUDA MICHAEL
-
Form 4 9 METERS BIOPHARMA, INC. For: Mar 29 Filed by: JOHNSON LORIN K
-
Form 4 9 METERS BIOPHARMA, INC. For: Mar 29 Filed by: Constantino Michael T.
-
Form 4 9 METERS BIOPHARMA, INC. For: Mar 29 Filed by: Ventimiglia Samantha
-
Form 4 9 METERS BIOPHARMA, INC. For: Mar 27 Filed by: Sensenig Bethany
-
Form 4 9 METERS BIOPHARMA, INC. For: Mar 27 Filed by: Temperato John
-
Form 10-K 9 METERS BIOPHARMA, INC. For: Dec 31
-
Form 8-K 9 METERS BIOPHARMA, INC. For: Mar 28
-
9 Meters Biopharma (NMTR) Provides Business Update, Reports Q4
-
9 Meters Biopharma Provides Business Update and Reports Financial Results for Fourth Quarter and Full Year 2022
-
9 Meter Biopharma (NMTR) PT Lowered to $40 at Brookline Capital Markets
-
Truist Securities Downgrades 9 Meter Biopharma (NMTR) to Hold
-
9 Meter Biopharma (NMTR) PT Lowered to $1.70 at Citi
-
Form 8-K 9 METERS BIOPHARMA, INC. For: Mar 13
-
9 Meters Biopharma Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
-
Form 424B5 9 METERS BIOPHARMA, INC.
-
9 Meters Biopharma (NMTR) Announces $5 Million Registered Direct Offering of Common Stock, Warrants
-
9 Meters Biopharma Announces $5 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
-
Form 8-K 9 METERS BIOPHARMA, INC. For: Mar 13
-
Form 8-K 9 METERS BIOPHARMA, INC. For: Mar 13
-
9 Meters Biopharma to Present at the Oppenheimer 33rd Annual Healthcare Conference
-
Citi Starts 9 Meter Biopharma (NMTR) at Neutral
Back to NMTR Stock Lookup